Baird Medical Investment Holdings Limited
Based in China, Baird Medical Investment Holdings Limited and its associated entities specialize in engineering and commercializing microwave ablation medical apparatus. These sophisticated instruments are employed in the minimally invasive management of a diverse array of benign and malignant tumors, notably targeting thyroid nodules, hepatic carcinomas, pulmonary cancers, and mammary lesions. The organization was established in 2012, with its corporate headquarters situated in Guangzhou, China.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2025 Q4 | -0.55 | $15M | $2M |
| 2025 Q2 | -0.43 | $8M | -$3M |
| 2024 Q4 | 0.38 | $24M | -$5M |
| 2024 Q2 | 0.58 | $13M | -$4M |
| 2023 Q4 | 0.38 | $20M | -$3M |
| 2023 Q2 | 0.08 | $12M | -$621,466 |